APLLTD — Alembic Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Alembic Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	611	755	1,202	835	2,103
Net Total Accounts Receivable
Net Total Receivables	10,687	12,338	11,861	15,857	14,770
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28,608	29,100	30,786	40,878	45,726
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	39,473	29,997	30,711	33,608	34,773
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	71,220	61,828	64,456	77,729	87,626
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17,165	16,369	14,550	24,123	25,938
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	18,845	18,124	16,274	25,820	30,878
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	52,376	43,705	48,182	51,909	56,748
Total Liabilities & Shareholders' Equity	71,220	61,828	64,456	77,729	87,626
Total Common Shares Outstanding